Actual Use Trial of Ibuprofen 400 mg

• Status: Completed
• Trial end date: 2015-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an open label, multicenter, 30 day study designed to mimic an OTC like environment in which subjects will use the product after making a purchase decision about ibuprofen 400 mg caplets based only on their reading of the Drug Facts Label (DFL) and other information on the package.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Ibuprofen

Criteria

Inclusion Criteria:

• Male or female at least 18 years of age (19 years of age in Alabama)

• Subject reports taking over-the-counter (OTC) analgesics for pain or fever relief

Exclusion Criteria:

• Current government-issued identification (ID)

• Pregnant or breastfeeding females